Brainsway Ltd
BRSYF
Market Cap$206.14M
Close$
$-1834.65
54060.2% downside
Current Fair Value
54060.2% downsideOvervalued by 54060.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $206.14 Million |
|---|---|
| Enterprise Value | $148.42 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.09 |
| Beta | 0.25 |
| Outstanding Shares | 34,768,959 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 67.48 |
|---|---|
| PEG | 6.03 |
| Price to Sales | 3.4 |
| Price to Book Ratio | 3.4 |
| Enterprise Value to Revenue | 3.62 |
| Enterprise Value to EBIT | 60.06 |
| Enterprise Value to Net Income | 50 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Brainsway Ltd.
CEO: Christopher von Jako Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the tr...